Biogen Vs. NovoCure Industry Stock Comparison

Sell

36

BIIB
Biogen

Last Price:

$143.68

Seasonality Move:

-1.77%

Sell

47

NVCR
NovoCure

Last Price:

$27.01

Seasonality Move:

5.69%

Sell

36

Biogen (BIIB) is a Sell

Is Biogen a Buy, Sell or Hold?

The current Biogen [BIIB] share price is $142.75. The Score for BIIB is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
BIIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

47

NovoCure (NVCR) is a Sell

Is NovoCure a Buy, Sell or Hold?

The current NovoCure [NVCR] share price is $26.83. The Score for NVCR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BIIB Stock Price Chart

What is Biogen's stock price today?

The Biogen share price today is $142.75

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIIB is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVCR Stock Price Chart

What is NovoCure's stock price today?

The NovoCure share price today is $26.83

The current trend is relatively stagnant and NVCR is experiencing slight buying pressure.

BIIB Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-3.96	Sell
Relative Strength Index (14 RSI):	35.55	Sell
Chaikin Money Flow:	822867	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(144.06 - 152.14)	Sell
Bollinger Bands (100):	(152.71 - 193.13)	Sell

NVCR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.16	Sell
Relative Strength Index (14 RSI):	45.67	Sell
Chaikin Money Flow:	11428	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(27.29 - 31.51)	Sell
Bollinger Bands (100):	(15.05 - 27.25)	Buy

BIIB Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	143.57	Sell
20-day SMA:	147.86	Sell
50-day SMA:	154.62	Sell
200-day SMA:	194.82	Sell
8-day EMA:	143.65	Sell
20-day EMA:	147.36	Sell
50-day EMA:	156.14	Sell
200-day EMA:	189.43	Sell

NVCR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	26.67	Buy
20-day SMA:	28.8	Sell
50-day SMA:	25.62	Buy
200-day SMA:	19.61	Buy
8-day EMA:	27.04	Sell
20-day EMA:	27.79	Sell
50-day EMA:	25.91	Buy
200-day EMA:	21.85	Buy

Biogen Earnings Growth & BIIB Earnings Dates

Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and an increase next year of $0.84 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.03 per share.

Biogen Technical Analysis

	Jan 7	Jan 8	Jan 10	Jan 13	Jan 14	Jan 15	Jan 16	Jan 17	Jan 21	Jan 22
	Jan
	07	08	10	13	14	15	16	17	21	22
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

	Jan 7	Jan 8	Jan 10	Jan 13	Jan 14	Jan 15	Jan 16	Jan 17	Jan 21	Jan 22
	Jan
	07	08	10	13	14	15	16	17	21	22
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):